A Unified Voice for Canadian Pharmaceutical Manufacturers
Welcome to the Canadian Pharmaceutical Manufacturers and Exporters Alliance (CPMEA), a trade alliance representing pharmaceutical companies that proudly manufacture in Canada. The CPMEA is a collaborative force committed to cultivating a strong domestic drug manufacturing sector and a resilient pharmaceutical supply chain in Canada.
Our members have united to tell the story about the economic impact and contribution of Canadian medicine producers, as well as the unique challenges we face. Our vision is to work with stakeholders to make Canada the very best country in the world for manufacturing medicines. CPMEA invites you to explore our initiatives and participate in shaping the future of pharmaceutical manufacturing in Canada.
A Unified Voice for Canadian Manufacturers
Welcome to the Canadian Pharmaceutical Manufacturers and Exporters Alliance (CPMEA), a trade alliance representing pharmaceutical companies that proudly manufacture in Canada. The CPMEA is a collaborative force committed to cultivating a strong domestic drug manufacturing sector and a resilient pharmaceutical supply chain in Canada.
Our members have united to tell the story about the economic impact and contribution of Canadian medicine producers, as well as the unique challenges we face. Our vision is to work with stakeholders to make Canada the very best country in the world for manufacturing medicines. CPMEA invites you to explore our initiatives and participate in shaping the future of pharmaceutical manufacturing in Canada.
80
"OVER
%
of the activities required to make the drugs sold in Canada are conducted in other countries…and the growing consolidation of global supply chains increases the likelihood of more shortages."
HEALTH CANADA
According to Statistics Canada, Canadian companies manufacture almost
$
13
BILLION
Canadians, and export more than
of pharmaceutical products, employ more than
$
9
BILLION
33
,000
in Canadian-made medicines to the U.S.
Canada is heavily reliant on imported medicines at a time of increasing national security concerns and geopolitical uncertainty. Action to ensure the sovereignty of our medicine supply and balance risk with a healthy manufacturing environment just makes good sense.
OUR VALUES
CANADA FIRST
Canadian pharmaceutical manufacturers are essential to a secure and reliable supply of medicines for Canadians. Domestic production reduces dependence on foreign sources, mitigates shortages, and ensures medicines are produced to the highest standards here at home. A strong manufacturing base is both a public health necessity and a strategic national economic asset.
OUR VALUES
ACCESS
We advocate for policies that ensure equitable and affordable access to essential medicines for all Canadians. Domestic manufacturers play a critical role in reducing barriers to access while supporting a healthcare system that delivers better outcomes and long-term sustainability.
OUR VALUES
TRUST
Trust is at the core of everything we do. Canadian pharmaceutical manufacturers are recognized globally for quality, safety, and regulatory excellence. Trust is earned through reliable supply, rigorous compliance, and an unwavering commitment to patient safety. Canadians can rely on domestic producers to deliver secure, high-quality medicines when they are needed most.
OUR VALUES
ECONOMIC SUSTAINABILITY
Canada’s pharmaceutical manufacturing sector is facing mounting pressure from global competition, rising costs, and evolving regulatory demands. The COVID-19 pandemic exposed the vulnerabilities of over-reliance on foreign supply chains and reinforced the necessity of local production. A sustainable domestic pharmaceutical manufacturing sector is critical to public health security and economic growth. CPMEA calls on all levels of government to prioritize Canadian pharmaceutical manufacturing as a strategic industry and to implement policies that support long-term investment, competitiveness, and supply sovereignty.
